Issue link: https://www.e-digitaleditions.com/i/1499694
6 BioPharm International ® Partnerships for Outsourcing eBook May 2023 www.biopharminternational.com Imdustry trends to another, is not something that is beneficial to any- one in the pharma industry," said Anil Kane, global head, Technical & Scientific Affairs, Thermo Fisher Scientific, in an interview with Pharmaceutical Tech- nology (13). "This is where a one-stop shop plays a role in helping partners bring medications to the patients sooner, faster, and in an efficacious manner." If companies continue to increasingly rely on out- sourcing companies to mitigate supply chain risks, full-service companies could become more of a manu- facturing norm. In this sense, outsourcing companies taking on increasing responsibilities can potentially increase their overall market use rate by companies who would otherwise look to other options. References 1. Grow t h+ Market Repor ts. Pharmaceutica l Out- sourcing Market by Services (Pharmaceutical Man- ufacturing Services, Drug Development Services), End-user (Big Pharmaceutical Companies, Generic Pharmaceutical Companies)—Global Outlook & Forecast 2022-2030; 1st edition; Growth+ Market Re- ports, Feb. 24, 2023. 2. L on z a . L on z a a nd Touc h l ig ht Col l a bor ate on E n d-t o -E n d m R N A O f f e r i n g. P r e s s R e l e a s e , Sept. 6, 2022. 3. AbbVie. AbbVie and Anima Biotech Announce Collab- oration for the Discovery and Development of mRNA Biology Modulators Against Oncology and Immunol- ogy Targets. Press Release, Jan. 10, 2023. 4. Moderna. Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Condition- ally Activated Therapeutics. Press Release, Jan. 5, 2023. 5. PharmTech Editors. Lonza and Singzyme Enter Bio- conjugates Partnership. PharmTech.com, Nov. 2, 2022. 6. Romeo, U. CordenPharma Expands Into GMP Lipid Nanoparticle Formulation in Caponago. cordenpharma. com, February 2023, 7. Playter, G. Illuminating the State of Outsourcing with Stephen Houldsworth. PharmTech.com, March 27, 2023. 8. Playter, G. Diving Deep into Oral Biologics with Gregor Kawaletz. PharmTech.com, April 20, 2023. 9. Playter, G. Exploring the Future of Outsourcing with Sarah Stevens. PharmTech.com, April 28, 2023. 10. PharmTech Editors. Sanofi and Insilico Medicine Ink $1.2 Billion Drug Development Deal. PharmTech.com, Nov. 16, 2022. 11. Regeneron. Regeneron and CytomX Announce Strate- gic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer. Press Release, Nov. 17, 2022. 12. Gilead. Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies. Press Release, Oct. 17, 2023. 13. Playter, G. Discussing the Growing Role of CDMOs with Anil Kane. PharmTech.com, March 29, 2023. ■ Gil Roth is the founder and president of the Pharma & Biopharma Outsourcing Association (PBOA). Tara Dougal is content director for the Pharma portfolio at Informa Markets. Challenges, Sustainability, and Big Trends in Outsourcing Today Following disruption in the bio/pharmaceutical supply chain as a result of the COVID pandemic, the outsourcing industry has learned to adapt and push forward in a climate that is dyamically different. In this Drug Solutions podcast episode, Pharmaceutical Technology ® spoke with Gil Roth, president of the Pharma & Biopharma Outsourcing Association (PBOA), and Tara Dougal, content director, Pharma portfolio, Informa Markets, on the current challenges facing the outsourcing industry today as well how contract service providers are tackling sustainability and other big trends in the industry. Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions— from the technologies, to strategies, to regulations related to the development and manufacture of drug products. For more podcast episodes, visit our website!